Webinar on

Stem Cell Research

September 24, 2021

Scientific Program

Keynote Session:

Oral Session 1:

  • Stem Cell Beats COVID -19 | Cancer Cell Science
Meetings International - Conference Keynote Speaker Yacob Mathai photo

Yacob Mathai

Marma Health Centre, India

Title: Does fever Increase or Decrease Blood Circulation?

Biography:

Dr. Yacob is a practicing physician in the field of healthcare in the state of Kerala in India for the last 33 years and has been very much interested in basic research. His interest is spread across the fever, inflammation and back pain.He is a writer.He already printed and published nine books on these subjects. He wrote hundreds of articles in various magazines.
After scientific studies, they have developed 8000 affirmative cross checking questions. It  can explain all queries related to fever.
 
 

Abstract:

Dr. Yacob is a practicing physician in the field of healthcare in the state of Kerala in India for the last 33 years and has been very much interested in basic research. His interest is spread across the fever, inflammation and back pain.He is a writer.He already printed and published nine books on these subjects. He wrote hundreds of articles in various magazines.
After scientific studies, they have developed 8000 affirmative cross checking questions. It  can explain all queries related to fever.
This is the first time many people have heard such a question.When it comes to treating back pain, neck pain, and knee pain, it is often heard that the cause of the pain is reduced blood flow. A variety of heat-inducing devices are used to increase blood flow to the lower back, neck, and knee pains. Physiotherapy often provides more heat than fever.To this day, no one has heard that fever is caused by poor blood flow.
As the disease progresses, blood flow decreases. Body tingling, body aches, and narrowing of the blood vessels under the skin are the signs, symptoms, and signals of decreased blood flow. Signs, symptoms, and signals of decreased blood flow show before the onset of fever.
When the disease becomes a threat to life or organs blood circulation decreases, Temperature of fever will emerge to increase prevailing blood circulation. 
It is a well-known fact that as the disease progresses, blood flow decreases and this can lead to death. When there is a decrease in blood flow and its signs, symptoms, and signals, the immune system do actions to increase blood flow to save lives. It has been proven around the world that all types of heat increase blood flow. The heat of the fever increases the blood flow. Fever increases blood flow, which means more lymphocytes flow through lymphoid tissues. If the heat of the fever increases the blood flow, reducing the heat reduces the blood flow. It will increase inflammation and infection and finally, death will occur. 
According to physics, it is foolish that when fever temperature is reduced, shows the symptoms, signs, and signals of reduced blood flow, are ignored and then treated to reduce the heat again. The fever is heat energy. To date, modern science has not studied what actions were carried out heat on fever.
The cause of all complications, including death, is the treatment of fever without knowing why it is hot.
What kind of treatment should be given if you have symptoms of decreased blood flow? Treatment should be to increase blood flow.
This is the basic principle of physics.
Is there any benefit in reducing body heat during fever? There is no merit of any kind. Not only is it of no benefit, but it also causes death by inflammation and infection.
The actual treatment for fever is to increase blood circulation. Two ways to increase blood circulation.
1. Never allow body temperature to lose
2. Apply heat from outside to the body. When the temperature produced by the body due to fever and heat which we applied to the body combines together, the blood circulation increases.
 Heat-reducing fever treatment with water and paracetamol should be banned as soon as possible.
Meetings International - Conference Keynote Speaker Michael Retsky photo

Michael Retsky

University College London, UK

Title: Breast Cancer And The perioperative Window

Biography:

Michael Retsky received a PhD in experimental physics from Universty of Chicago in 1974. His thesis project was to build a scanning transmission electron microscope that could resolve single atoms of silver, mercury and uranium and measure their elastic cross-sections. While working at Hewlett-Packard in 1982, a friend’s wife was diagnosed with cancer. This friend organized an informal research group to study cancer and possibly help his wife. Retsky got more interested in cancer research than physics research and gradually made a career change over a period of 5 years. HP did not object as long as Retsky got his work done. He read every paper he could find at Penrose Cancer Hospital. His first paper in oncology (Speer et al Cancer Research 1984) predicted that breast cancer growth included occasional periods of dormancy. Retsky developed skills in computer simulation at HP. He later became Prof of Biology at University of Colorado, Visting Prof at University of Texas (Wm. McGuire’s laboratory) and on Judah Folkman’s staff at Harvard Medical School. He is now Honorary Associate Professor at University College London.

 

Abstract:

 Most current research in cancer is attempting to find ways of preventing patients from dying after metastatic relapse. Driven by data and analysis, this project is an approach to solve the problem upstream, i.e., to prevent relapse. This project started with the unexpected observation of bimodal relapse patterns in breast and a number of other cancers. This was not explainable with the current cancer paradigm that has guided cancer therapy and early detection for many years. After much analysis using computer simulation and input from a number of medical specialists, we eventually came to the conclusion that the surgery to remove the primary tumor produced systemic inflammation for a week after surgery. This systemic inflammation apparently caused exits of cancer cells and avascular micrometastases from dormant states and resulted in relapses in the first 3 years post-surgery. Two animal studies agree with these findings It was determined in two retrospective studies that the common inexpensive perioperative NSAID ketorolac could curtail the early relapse events after breast cancer surgery. Ketorolac is routinely used at the surgeon’s option either before or after breast cancer surgery at Beth Israel Deaconess Medical Centre (Harvard). Based on what we now know, surgeons and anesthesiologists should take extra efforts to reduce systemic inflammation during the perioperative window.